Diabetes Mellitus: all 11,090 studies
Page 21 of 111. Open to participants first (1,319), then studies with results posted, then the rest; newest registration first within each.
- A Study to Evaluate the Efficacy and Safety of Ertugliflozin in Asian Participants With Type 2 Diabetes and Inadequate Glycemic Control on Metformin Monotherapy (MK-8835-012)CompletedNCT02630706Phase 3Results posted
- A Pilot Study of the Therapeutic Potential of Stem Cell Educator Therapy in Type 1 DiabetesCompletedNCT02624804Phase 1Results posted
- Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Sitagliptin (REMIT-Sita)CompletedNCT02623998Phase 3Results posted
- Metatarsal Phalangeal Joint Deformity Progression - R01CompletedNCT02616263Not applicableResults posted
- Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 DiabetesCompletedNCT02607865Phase 3Results posted
- A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus.CompletedNCT02607306Phase 3Results posted
- ACCU-CHEK Connect Personal Diabetes Management Study (PDM CONNECT)CompletedNCT02600845Not applicableResults posted
- Effects of Use of a Connected Pillbox On Medication AdherenceCompletedNCT02593032Not applicableResults posted
- Efficacy and Safety Study of Empagliflozin as add-on to Insulin in Japanese Patients With Type 2 Diabetes MellitusCompletedNCT02589639Phase 4Results posted
- Long-term Safety and Efficacy of Empagliflozin as Add on to GLP-1 RACompletedNCT02589626Phase 4Results posted
- A Study of U-500 Insulin (LY041001) in Participants With Type 2 DiabetesTerminatedNCT02588950Phase 1Results posted
- Improving Chronic Disease Management With PiecesCompletedNCT02587936Not applicableResults posted
- Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CADCompletedNCT02586155Phase 3Results posted
- Comparing Efficacy and Safety of Thrice Daily Versus Twice Daily NovoMix® 30 (Biphasic Insulin Aspart 30) in Subjects With Type 2 Diabetes Inadequately Controlled With Basal InsulinCompletedNCT02582242Phase 4Results posted
- Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3)CompletedNCT02580591Phase 3Results posted
- Double-blind Sitagliptin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Ipragliflozin (MK-0431J-842)CompletedNCT02577016Phase 3Results posted
- Double-blind Ipragliflozin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Sitagliptin (MK-0431J-843)CompletedNCT02577003Phase 3Results posted
- Evaluation of an Ascensia Blood Glucose Meter and App SystemCompletedNCT02568384Not applicableResults posted
- Ipragliflozin Add-on Long-term Study in Japanese Participants With Type 2 Diabetes Mellitus on Sitagliptin (MK-0431J-849)CompletedNCT02564211Phase 3Results posted
- Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With ForxigaCompletedNCT02561130Phase 4Results posted
- An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes MellitusCompletedNCT02561078Phase 3Results posted
- Feasibility of a Decision Support System to Reduce Glucose Variability in Subject With T1DMCompletedNCT02558491Not applicableResults posted
- PowerUp for Health: A Diabetes Prevention Program for MenCompletedNCT02555631Not applicableResults posted
- A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on MetforminCompletedNCT02551874Phase 3Results posted
- Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes MellitusCompletedNCT02548650Phase 4Results posted
- A Multiple-ascending-dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of MEDI0382 in Overweight and Obese Participants With Type 2 Diabetes MellitusCompletedNCT02548585Phase 1/2Results posted
- A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKDCompletedNCT02547935Phase 2/3Results posted
- Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney DiseaseCompletedNCT02545049Phase 3Results posted
- Bromocriptine Quick Release (BCQR) as Adjunct Therapy in Type 1 DiabetesCompletedNCT02544321Phase 2Results posted
- Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes PatientsCompletedNCT02542631Not applicableResults posted
- Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney DiseaseCompletedNCT02540993Phase 3Results posted
- Impact of Chronic Kidney Disease on the Effects of Ticagrelor in Patients With Diabetes and Coronary Artery DiseaseCompletedNCT02539160Phase 4Results posted
- A Study to Assess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea (MK-0431-838)CompletedNCT02532855Phase 3Results posted
- A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy AloneCompletedNCT02531035Phase 3Results posted
- Continuous Glucose Monitor in Children With Poorly Controlled DiabetesCompletedNCT02530450Results posted
- Afrezza Safety and Pharmacokinetics Study in Pediatric PatientsCompletedNCT02527265Phase 2Results posted
- Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DMCompletedNCT02526524Phase 2Results posted
- Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD)TerminatedNCT02525263Phase 2Results posted
- Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 DiabetesCompletedNCT02518945Phase 3Results posted
- Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in AsiaCompletedNCT02517866Phase 4Results posted
- Liraglutide in Adolescents With Type 1 DiabetesCompletedNCT02516657Phase 3Results posted
- Effect of 2-Week Nightly Moderate Hypoxia on Glucose Tolerance in Individuals With Type 2 DiabetesCompletedNCT02513641Not applicableResults posted
- A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal DiseaseCompletedNCT02512068Phase 3Results posted
- Diabetes Strengths Study - Pilot of Provider-delivered Strengths-based InterventionCompletedNCT02510664Not applicableResults posted
- The Set-Point Study: Evaluating Effects of Changing Glucose Target on Bionic Pancreas PerformanceCompletedNCT02509065Not applicableResults posted
- A Trial Comparing the Efficacy and Safety of Liraglutide 1.8 mg/Day to Liraglutide 0.9 mg/Day in Japanese Subjects With Type 2 Diabetes Mellitus.CompletedNCT02505334Phase 3Results posted
- A 104 Week Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes MellitusCompletedNCT02501161Phase 3Results posted
- Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes MellitusCompletedNCT02500979Phase 1Results posted
- Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 DiabetesCompletedNCT02500706Phase 3Results posted
- Shared Medical Decision Making in Pediatric DiabetesCompletedNCT02496156Not applicableResults posted
- Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes MellitusCompletedNCT02496000Phase 2Results posted
- A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)TerminatedNCT02492763Phase 2Results posted
- Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Japanese Patients With Type 2 Diabetes MellitusCompletedNCT02489968Phase 3Results posted
- Long Term Daily Use of JARDIANCE® Tablets in Japanese Patients With Type 2 Diabetes MellitusCompletedNCT02489942Results posted
- Impact of a Virtual Diabetes Self-Care and Education Program on Diabetes-related Outcomes in Latinos With T2 DiabetesCompletedNCT02488785Not applicableResults posted
- FAMS Mobile Health Intervention for Diabetes Self-care SupportCompletedNCT02481596Not applicableResults posted
- Pilot Study to Evaluate the Safety and Efficacy of 5-ALA-SFC in Type II DiabetesCompletedNCT02481141Not applicableResults posted
- Targeting Physical Activity to Improve Cardiovascular Health in Type 2 DiabetesCompletedNCT02473926Not applicableResults posted
- Efficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptin in Combination With Metformin in Type 2 Diabetes Patients Compared With SulphonylureaCompletedNCT02471404Phase 4Results posted
- Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes MellitusCompletedNCT02465515Phase 4Results posted
- EDCR Study - Etanercept Diamyd Combination Regimen -Open Trial to Evaluate Safety in Children With Type 1 DiabetesCompletedNCT02464033Phase 2Results posted
- Hybrid Closed Loop Pivotal Trial in Type 1 DiabetesCompletedNCT02463097Not applicableResults posted
- Pharmacogenetics of SGLT2 InhibitorsTerminatedNCT02462421Phase 4Results posted
- Testing Different Messaging Approaches to Increase Activation of a HealthyFood Benefit in Adults With DiabetesCompletedNCT02462057Not applicableResults posted
- Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 DiabetesCompletedNCT02461589Phase 2Results posted
- Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 DiabetesCompletedNCT02460978Phase 3Results posted
- Dose-ranging Study in Patients With Type 1 Diabetes MellitusCompletedNCT02459899Phase 2Results posted
- Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 DiabetesCompletedNCT02455076Phase 4Results posted
- Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes MellitusCompletedNCT02453711Phase 2Results posted
- A Study to Compare Insulin Intensification of Biphasic Insulin Aspart 30 and Insulin Analogues (Insulin Glargine and Insulin Aspart) in Insulin naïve Type 2 Diabetic PatientsCompletedNCT02453685Phase 4Results posted
- Empagliflozin Add on to Linagliptin Study in Japanese Patient With Type 2 Diabetes MellitusCompletedNCT02453555Phase 3Results posted
- A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo (ACHIEVE CONTROL REAL LIFE STUDY PROGRAM)CompletedNCT02451137Phase 4Results posted
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of KQ-791 in Diabetes MellitusCompletedNCT02445911Phase 1Results posted
- A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell FunctionCompletedNCT02443155Phase 2Results posted
- Relationship Between Insulin Resistance and Statin Induced Type 2 Diabetes, and Integrative Personal Omics ProfilingCompletedNCT02437084Phase 4Results posted
- Effects of Dapagliflozin 10 mg on Insulin Resistance in Patients With Type 2 Diabetes MellitusCompletedNCT02426541Phase 4Results posted
- Community Servings: Food as Medicine for DiabetesCompletedNCT02426138Not applicableResults posted
- Education Effectiveness for Type 1 Diabetes Mellitus on Insulin Pump TherapyCompletedNCT02423993Not applicableResults posted
- Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin TherapyCompletedNCT02421510Phase 3Results posted
- A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes MellitusCompletedNCT02420262Phase 3Results posted
- A 52-week International, Multicenter Trial With a Long -Term Extension to Evaluate Saxagliptin With Dapagliflozin in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin AloneCompletedNCT02419612Phase 3Results posted
- Can Vitamin D3 Improve Cognitive Function in Individuals With Type 2 Diabetes? (THINK-D)TerminatedNCT02416193Phase 2Results posted
- Memory Aid by Intranasal Insulin in Diabetes (MemAID)CompletedNCT02415556Phase 2Results posted
- Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2)CompletedNCT02414958Phase 3Results posted
- A Study to Evaluate the Effect of Dapagliflozin on Blood Glucose Level and Renal Safety in Patients With Type 2 DiabetesCompletedNCT02413398Phase 3Results posted
- Improving Medication Adherence Among Underserved Patients With Type 2 DiabetesCompletedNCT02409329Not applicableResults posted
- Benefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 DiabetesCompletedNCT02408120Phase 4Results posted
- Family Model of Diabetes Self-Management Education in the Marshallese CommunityCompletedNCT02407132Not applicableResults posted
- Effect of Momordica Charantia Administration on Type 2 Diabetes Mellitus, Insulin Sensitivity and Insulin SecretionCompletedNCT02397447Phase 2Results posted
- A Dose Range Finding Study to Evaluate the Effect of Bexagliflozin Tablets in Subjects With Type 2 Diabetes MellitusCompletedNCT02390050Phase 2Results posted
- Abbott Sensor Based Glucose Monitoring System Paediatric StudyCompletedNCT02388815Not applicableResults posted
- Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin TherapyCompletedNCT02384941Phase 3Results posted
- Efficacy and Safety of Sotagliflozin in Young Adult Patients With Type 1 Diabetes Mellitus and Elevated Hemoglobin A1CCompletedNCT02383940Phase 2Results posted
- Impact of an Interprofessional Shared Decision-making and Goal-setting Decision Aid for Patients With DiabetesCompletedNCT02379078Not applicableResults posted
- Risk of Nocturnal Hypoglycemia and Arrhythmias With Sitagliptin Versus Glimepiride in Patients With Type 2 DiabetesTerminatedNCT02373865Phase 4Results posted
- The Effect of LINAGLIPTIN on Inflammation, Oxidative Stress and Insulin Resistance in Obese Type 2 Diabetes SubjectsCompletedNCT02372630Phase 4Results posted
- Verapamil for Beta Cell Survival Therapy in Type 1 DiabetesCompletedNCT02372253Phase 2Results posted
- Lidocaine + Clonidine for Intraoral Anesthesia in Patients With Diabetes Mellitus Type 2CompletedNCT02371759Phase 3Results posted
- A Study to Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients With Type 2 Diabetes and Also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients With Different Degrees of PEICompletedNCT02370537Phase 2Results posted
- Daily Use of JARDIANCE® Tablets in Japanese Elderly Patients With Type 2 Diabetes MellitusCompletedNCT02367131Results posted